SCHEMBL9301263

SCHEMBL9301263

C[Sn](C)(C)c1ccc2c(c1)C(=O)c1ccc(CO)nc1-2

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.33
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9301771 0.78 BCL2 (0.49) CCR1MAOB
SCHEMBL9302270 0.75 CCR1 (0.33) CCR1MAOB
SCHEMBL9301241 0.74 USP8 (0.41) MAOB
SCHEMBL8896514 0.72 MAPT (0.44) MAOB
SCHEMBL9302208 0.72 TDP1 (0.55)
SCHEMBL9423285 0.71 CHEK1 (0.45) MAOB
SCHEMBL29117498 0.69 ELANE (0.55) MAOB
SCHEMBL9849269 0.68 ELANE (0.53)
SCHEMBL9302015 0.66 GAA (0.55)
SCHEMBL8976353 0.64 KDM4E (0.33) CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994009002-A1 2-(AZA-9-FLUORENONYL)CARBAPENEM ANTIBACTERIAL AGENTS MERCK & CO., INC. (US) 1994-04-28 WO disclosed
US-5294610-A Staphylococcus; side effect reduction MERCK & CO. INC. (US) 1994-03-15 US disclosed